TNF-α Antibody Therapy in Combination With the T-Cell–Specific Antibody Anti-TCR Reverses the Diabetic Metabolic State in the LEW.1AR1-iddm Rat

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Diabetes

• Publication date

  2015-03-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/db14-1866PMID 25784545
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes

  2015cited by this paper
• Current therapies for the treatment of systemic sclerosis-related pulmonary arterial hypertension: efficacy and safety

  2014cited by this paper
• Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes

  2014influential reference
• Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes

  2014cited by this paper
• Anti-TCR therapy combined with fingolimod for reversal of diabetic hyperglycemia by β cell regeneration in the LEW.1AR1-iddm rat model of type 1 diabetes

  2014influential reference
• Combination Therapy With an Anti–IL-1β Antibody and GAD65 DNA Vaccine Can Reverse Recent-Onset Diabetes in the RIP-GP Mouse Model

  2014cited by this paper
• Safety of anti-tumor necrosis factor agents in psoriatic arthritis – an update

  2014cited by this paper
• Combination therapy for preservation of beta cell function in Type 1 diabetes: new attitudes and strategies are needed!

  2014cited by this paper
• Expression of IL-2, IL-17 and TNF-alpha in patients with Crohn's disease treated with anti-TNF antibodies.

  2014cited by this paper
• Immune modulation in humans: implications for type 1 diabetes mellitus

  2014cited by this paper
• TNF-α gene polymorphisms: association with disease susceptibility and response to anti-TNF-α treatment in psoriatic arthritis.

  2014cited by this paper
• What is the role of autoimmunity in type 1 diabetes? A clinical perspective

  2014cited by this paper
• Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial

  2013cited by this paper
• Crohn's disease: a review of treatment options and current research.

  2013cited by this paper
• Anti-cytokine therapies in T1D: Concepts and strategies.

  2013cited by this paper
• Non-antigenic and antigenic interventions in type 1 diabetes

  2013cited by this paper
• Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lactococcus lactis in mice.

  2012cited by this paper
• The Role of TNF-α in Mice with Type 1- and 2- Diabetes

  2012cited by this paper
• The problems and promises of research into human immunology and autoimmune disease

  2012cited by this paper
• Clinical immunologic interventions for the treatment of type 1 diabetes.

  2012cited by this paper
• The Role of TNF-\(\alpha\) in Mice with Type 1- and 2- Diabetes

  2012cited by this paper
• Human β-Cell Killing by Autoreactive Preproinsulin-Specific CD8 T Cells Is Predominantly Granule-Mediated With the Potency Dependent Upon T-Cell Receptor Avidity

  2012cited by this paper
• Anti-TNF therapy: what have we learned in 12 years?

  2011influential reference
• Synergistic Reversal of Type 1 Diabetes in NOD Mice With Anti-CD3 and Interleukin-1 Blockade

  2011cited by this paper
• Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

  2011cited by this paper
• Genetics, pathogenesis and clinical interventions in type 1 diabetes

  2010cited by this paper
• Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

  2010cited by this paper
• Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN–JDRF Type 1 Diabetes Combination Therapy Assessment Group

  2010cited by this paper
• Diabetes prevention by immunomodulatory FTY720 treatment in the LEW.1AR1-iddm rat despite immune cell activation.

  2010influential reference
• Immune therapy for type 1 diabetes mellitus—what is unique about anti-CD3 antibodies?

  2010influential reference
• Anti-TNFalpha therapy--killing two birds with one stone?

  2010cited by this paper
• Combination therapies for type 1 diabetes: why not now?

  2010cited by this paper
• Tumor necrosis factor-α signaling in macrophages.

  2010cited by this paper
• β-Cell Growth and Regeneration: Replication Is Only Part of the Story

  2010cited by this paper
• Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot Randomized, Placebo-Controlled, Double-Blind Study

  2009cited by this paper
• Prevention of spontaneous immune-mediated diabetes development in the LEW.1AR1-iddm rat by selective CD8+ T cell transfer is associated with a cytokine shift in the pancreas-draining lymph nodes

  2009cited by this paper
• Etanercept Treatment in Children With New-Onset Type 1 Diabetes

  2009cited by this paper
• Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot Randomized, Placebo-Controlled, Double-Blind Study

  2009cited by this paper
• Oxidative stress: the vulnerable beta-cell.

  2008cited by this paper
• Determinants of pancreatic β‐cell regeneration

  2008cited by this paper
• Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.

  2007cited by this paper
• Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission

  2007cited by this paper
• Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs.

  2006cited by this paper
• Caspase-3-Dependent β-Cell Apoptosis in the Initiation of Autoimmune Diabetes Mellitus

  2005cited by this paper
• Immune cell infiltration, cytokine expression, and beta-cell apoptosis during the development of type 1 diabetes in the spontaneously diabetic LEW.1AR1/Ztm-iddm rat.

  2005cited by this paper
• Development of anti-TNF therapy for rheumatoid arthritis

  2002cited by this paper
• The LEW.1AR1/Ztm-iddm rat: a new model of spontaneous insulin-dependent diabetes mellitus

  2001influential reference
• Potential role of resident islet macrophage activation in the initiation of autoimmune diabetes.

  1998influential reference
• A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.

  1997cited by this paper
• Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.

  1994cited by this paper
• Anti‐α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice

  1991cited by this paper
• Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice.

  1991cited by this paper
• A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes

  1989cited by this paper

• Autoimmune Form des Typ-1-Diabetes mellitus: Mit Kombinationstherapie einer Heilung näher kommen

  2024cites this paper
• Therapy concepts in type 1 diabetes mellitus treatment: disease modifying versus curative approaches

  2024cites this paper
• Receptors and Signaling Pathways Controlling Beta-Cell Function and Survival as Targets for Anti-Diabetic Therapeutic Strategies

  2024cites this paper
• Fucoidan alleviated autoimmune diabetes in NOD mice by regulating pancreatic autophagy through the AMPK/mTOR1/TFEB pathway

  2024cites this paper
• Preservation of β-Cells as a Therapeutic Strategy for Diabetes

  2023cites this paper
• Pharmacological inhibitors of β-cell dysfunction and death as therapeutics for diabetes

  2023cites this paper
• T cells and their products in diabetic kidney disease

  2023cites this paper
• Advanced Glycation End-Products (AGEs) of Lysine and Effects of Anti-TCR/Anti-TNF-α Antibody-Based Therapy in the LEW.1AR1-iddm Rat, an Animal Model of Human Type 1 Diabetes

  2022cites this paper
• Activation of the STING‐IRF3 pathway involved in psoriasis with diabetes mellitus

  2022cites this paper
• The pancreatic beta cell: an intricate relation between anatomical structure, the signalling mechanism of glucose-induced insulin secretion, the low antioxidative defence, the high vulnerability and sensitivity to diabetic stress

  2021cites this paper
• Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes

  2020cites this paper
• Pancreas Pathology of Latent Autoimmune Diabetes in Adults (LADA) in Patients and in a LADA Rat Model Compared With Type 1 Diabetes

  2020cites this paper
• Rat Models of Human Type 1 Diabetes.

  2020cites this paper
• Translation of curative therapy concepts with T cell and cytokine antibody combinations for type 1 diabetes reversal in the IDDM rat

  2020cites this paper
• Asymmetric dimethylation and citrullination in the LEW.1AR1-iddm rat, an animal model of human type 1 diabetes, and effects of anti-TCR/anti-TNF-α antibody-based therapy

  2019cites this paper
• MCPIP1 regulates the sensitivity of pancreatic beta-cells to cytokine toxicity

  2019cites this paper
• CD4+ αβ T cell infiltration into the leptomeninges of lumbar dorsal roots contributes to the transition from acute to chronic mechanical allodynia after adult rat tibial nerve injuries

  2018cites this paper
• Restoration of mucosal integrity and epithelial transport function by concomitant anti-TNFα treatment in chronic DSS-induced colitis

  2018cites this paper
• Chemistry and biology of reactive species with special reference to the antioxidative defence status in pancreatic β-cells.

  2017cites this paper
• Dominant TNFα and impaired IL‐2 cytokine profiles of CD4+ T cells from children with type‐1 diabetes

  2017cites this paper
• Animal Models of Type 1 and Type 2 Diabetes Mellitus

  2017cites this paper
• Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes

  2017cites this paper
• Animal models of human type 1 diabetes for evaluating combination therapies and successful translation to the patient with type 1 diabetes

  2017cites this paper
• Animal models for diabetes: Understanding the pathogenesis and finding new treatments.

  2016cites this paper
• Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases

  2015cites this paper